Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Statin and COX-2 Inhibitor Exposure Is Associated with Improved Survival in 4913 Newly Diagnosed DLBCL Patients: A Large Population Based Study

Liam Smyth, MDFRCPath, Danielle N. Blunt, BMBS, Evgenia Gatov, Chenthila Nagamuthu, MPH, Ruth Croxford, MSc, Lee Mozessohn, MD, Matthew Cheung, MDMSc

Blood (2019) 134 (Supplement_1): 3476.

https://doi.org/10.1182/blood-2019-127156

Published: 2019

Journal Articles

FOS Expression Distinguishes Two Groups of Atypical CML (aCML) Allowing Targeted Therapy

Manja Meggendorfer, PhD, Wencke Walter, PhD, Stephan Hutter, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2018) 132 (Supplement 1): 3893.

https://doi.org/10.1182/blood-2018-99-111832

Published: 2018

Journal Articles

Characterization of Myeloid-Derived Suppressor Cells and Tumor Associated Macrophages Using MultiOmyx TM Hyperplexed Immunofluorescence Assay in Hodgkin Lymphoma

Qingyan Au, PhD, Jun Fang, PhD, Anna Juncker-Jensen, PhD, Judy Kuo, Eric Leones, Flora Sahafi, RaghavKrishna Padmanabhan, PhD, Nicholas Hoe, PhD, Josette William, MD, PhD

Blood (2018) 132 (Supplement 1): 4135.

https://doi.org/10.1182/blood-2018-99-115434

Published: 2018

Journal Articles

Novel ARC//IL1β/PGE2/β-Catenin/ARC Circuit Regulates Leukemia and Leukemia Microenvironment and Drug Resistance in AML

Bing Z Carter, PhD, Po Yee Mak, Xiangmeng Wang, PhD, Hong Mu, MD PhD, Wenjing Tao, PhD, Vivian Ruvolo, PhD, Michael Andreeff, MD PhD

Blood (2017) 130 (Supplement 1): 3776.

https://doi.org/10.1182/blood.V130.Suppl_1.3776.3776

Published: 2017

Journal Articles

Biomodulatory Metronomic Therapy Shows Remarkable Activity in Chemorefractory Multi-System Langerhans Cell Histiocytosis

Daniel Heudobler, MD, Klaus Rehe, MD PhD, Juergen Foell, MD, Selim Corbacioglu, MD, Gerhard Hildebrandt, MD, Wolfgang Herr, MD, Albrecht Reichle, MD, Martin Vogelhuber, MD

Blood (2016) 128 (22): 4254.

https://doi.org/10.1182/blood.V128.22.4254.4254

Published: 2016

Journal Articles

PGE2 Promotes BM Hematopoietic Stem Cell Retention Via Stromal Lactate Production, cAMP and CXCL12/CXCR4 Regulation

Anju Kumari, PhD, Aya Ludin, DMD, PhD, Karin Golan, PhD, Orit Kollet, PhD, Elisabeth Niemeyer, MD, Nitzan Friedlander, BSc, Tsvee Lapidot, PhD

Blood (2014) 124 (21): 771.

https://doi.org/10.1182/blood.V124.21.771.771

Published: 2014

Journal Articles

Hepatic Stellate Cell Conditioned Myeloid Cells Provide a Novel Therapy for Prevention of Factor VIII Antibody Formation in the Hemophilia A Mouse Model

Sumantha Bhatt, Kathleen Brown, Feng Lin, Ph.D., Michael P Meyer, Margaret V. Ragni, MD, MPH, Lina Lu, Ph.D.

Blood (2012) 120 (21): 4117.

https://doi.org/10.1182/blood.V120.21.4117.4117

Published: 2012

Journal Articles

Quality Controls of Immune Regulatory Properties of Ex-Vivo, GMP -Grade Expanded Mesenchymal Stromal Cells for Clinical Use (European multicenter study CASCADE),

Mauro Krampera, Cedric Mènard, Luciano Pacelli, Giulio Bassi, Joelle Dulong, Isabelle Bezier, Francesco Bifari, Jasmina Zanoncello, Hubert Schrezenmeier, MD, Luc Sensebé, Karin Tarte

Blood (2011) 118 (21): 4049.

https://doi.org/10.1182/blood.V118.21.4049.4049

Published: 2011

Journal Articles

Prostaglandin E 2 Modulates Monocytes and Dendritic Cells Specific Progenitor Cell (MDP) Fate by Regulating M-CSF Receptor and Flt3 Receptor Expression.

Pratibha Singh,, PhD, Jonathan Hoggatt, PhD, Jennifer Speth, Louis M. Pelus, PhD

Blood (2010) 116 (21): 2636.

https://doi.org/10.1182/blood.V116.21.2636.2636

Published: 2010

Journal Articles

Acute Tumor Lysis Syndrome. Modulation of Cyclooxygenase-2, Alpha V Beta Integrin and Microsomal Prostaglandin E Synthase-1 In Human Immunodeficiency Virus-1 (HIV-1) Squamous Cell Carcinoma (SCC) of the Penis with Selenomethionine/Nsaids

Eugene McPherson, MD, PhD

Blood (2010) 116 (21): 4880.

https://doi.org/10.1182/blood.V116.21.4880.4880

Published: 2010

Journal Articles

Targeting Myeloma Stem Cells through Simultaneous Inhibition of Wnt and Hedgehog (Hh) Signaling Pathways

Guido J. Tricot, MD, PhD, Ye Yang, PhD, Chujiao Xu, PhD, Hongwei Xu, MS, Ming Zeng, PhD, Maurizio Zangari, MD, Fenghuang Zhan, MD, PhD

Blood (2010) 116 (21): 615.

https://doi.org/10.1182/blood.V116.21.615.615

Published: 2010

Journal Articles

The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy

Alfredo Dragani, Silvia Pascale, Antonio Recchiuti, Domenico Mattoscio, Stefano Lattanzio, Giovanna Petrucci, Luciana Mucci, Elisabetta Ferrante, Aida Habib, Franco O. Ranelletti, Giovanni Ciabattoni, Giovanni Davì, Carlo Patrono, Bianca Rocca

Blood (2010) 115 (5): 1054–1061.

https://doi.org/10.1182/blood-2009-08-236679

Published: 2010

Journal Articles

The tale of two COXs

A. Koneti Rao

Blood (2010) 115 (5): 921–922.

https://doi.org/10.1182/blood-2009-11-254052

Published: 2010

Journal Articles

Cyclooxygenase-2 Derived Prostaglandin E2 Is Required for Dendritic Cell Differentiation From Hematopoietic Progenitor Cells.

Pratibha Singh, PhD, Jonathan Hoggatt, MS, Jennifer M. Speth, MS, Louis M. Pelus, PhD

Blood (2009) 114 (22): 1499.

https://doi.org/10.1182/blood.V114.22.1499.1499

Published: 2009

Journal Articles

Myeloid-Derived Suppressor Cells in Multiple Myeloma.

Els Van Valckenborgh, Jo Van Ginderachter, Kiavash Movahedi, Eline Menu, Karin Vanderkerken

Blood (2009) 114 (22): 2794.

https://doi.org/10.1182/blood.V114.22.2794.2794

Published: 2009

Journal Articles

Potential Eradication of Myeloma Stem Cells by Combining ATRA with WNT and HH Signaling Pathways Inhibitors.

Guido J. Tricot, MD, PhD, Siqing Wang, MD, MS, Lei Shi, MD, Hongwei Xu, MD, Chunjiao Xu, MD, PhD, Maurizio Zangari, MD, Fenghuang Zhan, MD, PhD

Blood (2009) 114 (22): 2839.

https://doi.org/10.1182/blood.V114.22.2839.2839

Published: 2009

Journal Articles

β-Catenin Determines Developmental Stage Specific Transformation by Hox Genes.

Yingzi Wang, PhD, Andrei V. Krivtsov, PhD, Amit U. Sinha, PhD, Trista North, PhD, Wolfram Goessling, MD, PhD, Leonard I. Zon, MD, Scott Armstrong, MD, PhD

Blood (2009) 114 (22): 385.

https://doi.org/10.1182/blood.V114.22.385.385

Published: 2009

Journal Articles

Combination of ATRA with a COX2 Inhibitor Induces Synergistic Effects On RARalpha2-Expressing Multiple Myeloma (MM) Cells.

Siqing Wang, MD, MS, Lei Shi, MD, Hongwei Xu, MD, Chunjiao Xu, MD, PhD, Maurizio Zangari, MD, Guido J. Tricot, MD, PhD, Fenghuang Zhan, MD, PhD

Blood (2009) 114 (22): 2809.

https://doi.org/10.1182/blood.V114.22.2809.2809

Published: 2009

Journal Articles

p53 and COX-2 Inhibitors Control the Replication and Viability of Non-Transformed and CLL B Lymphocytes

Patricia Mongini, Ph.D., Matthew Kaufman, M.D., Jonathan E. Kolitz, MD, Steven L. Allen, M.D., Joshua Trott, Kanti Rai, M.D., Nicholas Chiorazzi, MD

Blood (2008) 112 (11): 3146.

https://doi.org/10.1182/blood.V112.11.3146.3146

Published: 2008

Journal Articles

Celecoxib Does Not Delay Cutaneous Wound Healing in Hemophilia B Mice.

Shan Pradhan, MD, Maureane Hoffman, MD, PhD, Dougald M. Monroe, III, PhD

Blood (2008) 112 (11): 1228.

https://doi.org/10.1182/blood.V112.11.1228.1228

Published: 2008

NARROW

Statin and COX-2 Inhibitor Exposure Is Associated with Improved Survival in 4913 Newly Diagnosed DLBCL Patients: A Large Population Based Study

FOS Expression Distinguishes Two Groups of Atypical CML (aCML) Allowing Targeted Therapy

Characterization of Myeloid-Derived Suppressor Cells and Tumor Associated Macrophages Using MultiOmyx TM Hyperplexed Immunofluorescence Assay in Hodgkin Lymphoma

Novel ARC//IL1β/PGE2/β-Catenin/ARC Circuit Regulates Leukemia and Leukemia Microenvironment and Drug Resistance in AML

Biomodulatory Metronomic Therapy Shows Remarkable Activity in Chemorefractory Multi-System Langerhans Cell Histiocytosis

PGE2 Promotes BM Hematopoietic Stem Cell Retention Via Stromal Lactate Production, cAMP and CXCL12/CXCR4 Regulation

Hepatic Stellate Cell Conditioned Myeloid Cells Provide a Novel Therapy for Prevention of Factor VIII Antibody Formation in the Hemophilia A Mouse Model

Quality Controls of Immune Regulatory Properties of Ex-Vivo, GMP -Grade Expanded Mesenchymal Stromal Cells for Clinical Use (European multicenter study CASCADE),

Prostaglandin E 2 Modulates Monocytes and Dendritic Cells Specific Progenitor Cell (MDP) Fate by Regulating M-CSF Receptor and Flt3 Receptor Expression.

Acute Tumor Lysis Syndrome. Modulation of Cyclooxygenase-2, Alpha V Beta Integrin and Microsomal Prostaglandin E Synthase-1 In Human Immunodeficiency Virus-1 (HIV-1) Squamous Cell Carcinoma (SCC) of the Penis with Selenomethionine/Nsaids

Targeting Myeloma Stem Cells through Simultaneous Inhibition of Wnt and Hedgehog (Hh) Signaling Pathways

The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy

The tale of two COXs

Cyclooxygenase-2 Derived Prostaglandin E2 Is Required for Dendritic Cell Differentiation From Hematopoietic Progenitor Cells.

Myeloid-Derived Suppressor Cells in Multiple Myeloma.

Potential Eradication of Myeloma Stem Cells by Combining ATRA with WNT and HH Signaling Pathways Inhibitors.

β-Catenin Determines Developmental Stage Specific Transformation by Hox Genes.

Combination of ATRA with a COX2 Inhibitor Induces Synergistic Effects On RARalpha2-Expressing Multiple Myeloma (MM) Cells.

p53 and COX-2 Inhibitors Control the Replication and Viability of Non-Transformed and CLL B Lymphocytes

Celecoxib Does Not Delay Cutaneous Wound Healing in Hemophilia B Mice.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only